AstraZeneca announced a major agreement with President Donald J. Trump's administration aimed at reducing the cost of prescription medicines for American patients while supporting domestic pharmaceutical innovation.
Under the deal, AstraZeneca will offer Direct-to-Consumer (DTC) sales at discounts of up to 80% off list prices for eligible patients with prescriptions for chronic conditions. These discounted medicines will be available through the TrumpRx.gov platform, enabling patients to purchase directly from AstraZeneca at reduced cash prices.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.